Theravance Biopharma, Inc. Reports Second Quarter 2016 Financial Results and Provides Business Update

Go back to Theravance Biopharma, Inc. Reports Second Quarter 2016 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Misses Q2 EPS by 1c

August 8, 2016 4:44 PM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($1.06), $0.01 worse than the analyst estimate of ($1.05).

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

... More